Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
adult vaccines
Biotech
FDA delays decision on Moderna's RSV shot until the end of May
Investors were largely undeterred by the FDA delaying a decision on Moderna's RSV candidate until the end of May.
Max Bayer
May 10, 2024 10:30am
Moderna won't advance US-backed Zika vaccine without more money
Mar 15, 2024 11:10am
J&J ends R&D at Janssen's infectious disease and vaccine unit
Aug 23, 2023 11:32am
BIO: Moderna to test mpox vaccine in humans this summer
Jun 7, 2023 9:25am
GSK vaccine R&D head touts full RSV data but mum on maternal plans
Feb 15, 2023 5:25pm
Moderna posts come-from-behind RSV data
Jan 17, 2023 4:55pm